Gary L. Disbrow

1.5k citations

26 papers · 1.1k indexed · 1 hit paper · h-index 17

Epidemiology top 5%
- Cervical Cancer and HPV Research 6
- Sepsis Diagnosis and Treatment 5
Critical Care and Intensive Care Medicine top 5%
Family Practice top 10%
Immunology
Oncology
- Cancer-related Molecular Pathways 5
Infectious Diseases
- Viral Infections and Outbreaks Research 7
- SARS-CoV-2 and COVID-19 Research 2
Genetics
- Virus-based gene therapy research 6
Emergency Medicine
- Emergency and Acute Care Studies 4
Modeling and Simulation
- COVID-19 epidemiological studies 2

Co-authors: Richard Schlegel John A. Hanover Hang Yuan Xuefeng Liu Astrid Baege Carl C. Baker Sybil M. Genther Williams David W. Threadgill
Cited by: Epidemiology Critical Care and Intensive Care Medicine Family Practice
Journals: Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (1 paper)Cancer Research (2 papers)
Partner nations: United States Somalia

In The Last Decade

Gary L. Disbrow

25 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Gary L. Disbrow

Since Specialization

Citations

This map shows the geographic impact of Gary L. Disbrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Disbrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Disbrow more than expected).

Fields of papers citing papers by Gary L. Disbrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Disbrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Disbrow. The network helps show where Gary L. Disbrow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary L. Disbrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary L. Disbrow Line = papers co-authored together Gary L. Disbrow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority Health Security ·Robert A. Johnson,Terence M. Barnhart,Gary L. Disbrow	2025	1
2	Project NextGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future Clinical Infectious Diseases ·Kimberly A. Hofmeyer,Christy L. Ventura,Kimberly L. Armstrong,Christopher R. Houchens,Sandeep Patel,Gary L. Disbrow,Robert A. Johnson,(unknown),Aaron C. Bandremer,John H. Beigel,Timothy T Belski,Rubén O. Donis,Lakshmi Jayashankar,Richard A. Koup,Gerald R. Kovacs,Malen A. Link,Karen Martins,Robin M Mason,Sabrina M Stronsky,Daniel Wolfe	2024	6
3	How Global Collaboration Can Improve the Medical Countermeasure Life Cycle for Infectious Disease Outbreaks The Journal of Infectious Diseases ·Jessica Swenson,Gary L. Disbrow,Robert A. Johnson	2024	4
4	Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning Human Vaccines & Immunotherapeutics ·Robert A. Johnson,Richard C. White,Gary L. Disbrow	2022	3
5	Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries☆ Vaccine ·Timothy G. Buchman,Steven Q. Simpson,Kimberly L. Sciarretta,Kristen Finne,Nicole Sowers,Michael Collier,Saurabh Chavan,Rose Do,Cheng‐Chieh Lin,Ibijoke Oke,Kiersten E. Rhodes,Aathira Santhosh,Alexander T. Sandhu,Steve Chu,Sandeep Patel,Gary L. Disbrow,Rick A. Bright,Thomas MaCurdy,Jeffrey A. Kelman	2021	2
6	Sepsis Among Medicare Beneficiaries: 4. Precoronavirus Disease 2019 Update January 2012–February 2020 Critical Care Medicine ·Charles E. Frank,Timothy G. Buchman,Steven Q. Simpson,Kimberly L. Sciarretta,George E. Plopper,Kristen Finne,Nicole Sowers,Michael Collier,Saurabh Chavan,Cheng‐Chieh Lin,Ibijoke Oke,Kiersten E. Rhodes,Aathira Santhosh,Steve Chu,Thomas MaCurdy,Sandeep Patel,Gary L. Disbrow,Jeffrey A. Kelman	2021	12
7	Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018breakdown → Critical Care Medicine* ·Timothy G. Buchman,Steven Q. Simpson,Kimberly L. Sciarretta,Kristen Finne,Nicole Sowers,Michael Collier,Saurabh Chavan,Ibijoke Oke,Meghan E. Pennini,Aathira Santhosh,Marie Wax,Robyn Woodbury,Steve Chu,Tyler G. Merkeley,Gary L. Disbrow,Rick A. Bright,Thomas MaCurdy,Jeffrey A. Kelman	2020	177
8	Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018* Critical Care Medicine ·Timothy G. Buchman,Steven Q. Simpson,Kimberly L. Sciarretta,Kristen Finne,Nicole Sowers,Michael Collier,Saurabh Chavan,Ibijoke Oke,Meghan E. Pennini,Aathira Santhosh,Marie Wax,Robyn Woodbury,Steve Chu,Tyler G. Merkeley,Gary L. Disbrow,Rick A. Bright,Thomas MaCurdy,Jeffrey A. Kelman	2020	45
9	Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks PLoS neglected tropical diseases ·Eric M. Espeland,Chiawei W. Tsai,Joseph C. Larsen,Gary L. Disbrow	2018	8
10	Project BioShield and the Biomedical Advanced Research Development Authority: A 10-Year Progress Report on Meeting US Preparedness Objectives for Threat Agents Clinical Infectious Diseases ·Joseph C. Larsen,Gary L. Disbrow	2017	27
11	Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs Vaccine ·Daniel Wolfe,Amanda G. Zarrabian,Gary L. Disbrow,Eric M. Espeland	2017	7
12	THE U.S. GOVERNMENT'S MEDICAL COUNTERMEASURE PORTFOLIO MANAGEMENT FOR NUCLEAR AND RADIOLOGICAL EMERGENCIES: SYNERGY FROM INTERAGENCY COOPERATION Health Physics ·Marcy B. Grace,Kenneth D. Cliffer,Brian R. Moyer,C. Norman Coleman,Joanna M. Prasher,Richard Hatchett,J. R. Mercier,Ronald G. Manning,Judith L. Bader,Gary L. Disbrow,Gerald R. Kovacs	2011	9
13	Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant Breast Cancer Research and Treatment ·Clare A. Thibodeaux,Xuefeng Liu,Gary L. Disbrow,Yiyu Zhang,Janice D. Rone,Bassem R. Haddad,Richard Schlegel	2008	22
14	HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells Oncogene ·Frank A. Suprynowicz,Gary L. Disbrow,Ewa Krawczyk,Vera Simić,K Lantzky,Richard Schlegel	2007	70
15	Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes Journal of Virology ·Xuefeng Liu,Gary L. Disbrow,Hang Yuan,Vjekoslav Tomaić,Richard Schlegel	2007	40
16	The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein Journal of Biological Chemistry ·Xuefeng Liu,Hang Yuan,Baojin Fu,Gary L. Disbrow,Tania Apolinario,Vjekoslav Tomaić,Melissa L. Kelley,Carl C. Baker,Jon M. Huibregtse,Richard Schlegel	2005	88
17	Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology ·Frank A. Suprynowicz,Gary L. Disbrow,Vera Simić,Richard Schlegel	2004	23
18	IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis Journal of Virology ·Astrid Baege,Gary L. Disbrow,Richard Schlegel	2004	23
19	Codon optimization of the HPV-16 E5 gene enhances protein expression Virology ·Gary L. Disbrow,Iruvanti Sunitha,Carl C. Baker,John A. Hanover,Richard Schlegel	2003	65
20	Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins American Journal Of Pathology ·Allison Berger,Astrid Baege,Tracy Guillemette,James Deeds,Ron Meyer,Gary L. Disbrow,Richard Schlegel,Robert Schlegel	2002	24

About Gary L. Disbrow

Gary L. Disbrow is a scholar working on Modeling and Simulation, Emergency Medicine and Infectious Diseases, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (7 papers), Virus-based gene therapy research (6 papers), Cervical Cancer and HPV Research (6 papers), Sepsis Diagnosis and Treatment (5 papers), Cancer-related Molecular Pathways (5 papers), Emergency and Acute Care Studies (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 epidemiological studies (2 papers). The work is most often cited by research in Epidemiology (568 citations), Critical Care and Intensive Care Medicine (75 citations) and Family Practice (30 citations). Gary L. Disbrow has collaborated with scholars based in United States and Somalia. Frequent co-authors include Richard Schlegel, John A. Hanover, Hang Yuan, Xuefeng Liu, Astrid Baege, Carl C. Baker, Sybil M. Genther Williams, David W. Threadgill, Paul F. Lambert and Daekee Lee. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact